Rapha Capital Management, LLC
Venture capitalSurfside · Seed–Series A · 1 people tracked
Also known as Rapha Capital Bioventures · Rapha Capital PE Life Sciences
Find your way into Rapha Capital Management, LLC
116 people in our graph share verified history with the Rapha Capital Management, LLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Rapha Capital Management concentrates on discovering potentially disruptive biopharmaceutical companies among a broad field of less compelling opportunities. The firm aims to identify and nurture revolutionary ideas across medicine, healthcare and technology, seeking to recognize their value earlier than other investors.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directories
What they invest in
from 19 of 22 portfolio companiesBiotech ×15Healthtech ×10Longevity ×8Deep Tech ×7Medical Devices ×4Consumer ×2New Materials ×2Advanced Manufacturing ×1
HQs:United States×17
Who they back
founder profiles across 15 portfolio companiesFounding team size:solo founder×112 founders×33 founders×1
Investments · 22 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12020 · 12018 · 14 dated
PartnerKevin M. Slawin· solo GP
Co-investorsAurum Venture PartnersBlue CollectiveExpaVU Venture PartnersFlucas Ventures
Biopharmaceutical company using computational biology to identify and develop novel peptide therapies, including AXT107 for retinal/eye diseases.
BiotechBethesda, US
Aleksander S. Popel, PhD(Executive Officer, Director)Jordan J. Green(Executive Officer, Director)inWendy Perrow(Executive Officer, Director)in
PartnerKevin M. Slawin· solo GP
Co-investorsPerceptive Xontogeny Venture
PartnerKevin M. Slawin· solo GP
Co-investorsAvoro Capital AdvisorsSolasta Ventures
DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets.
BiotechDeep TechHealthtechLongevityHouston, US
Kevin Slawin(Founder)in
PartnerKevin M. Slawin· solo GP
Deliver Therapeutics develops small molecule and peptide therapeutics using DNA-encoded library screening to address difficult and previously undruggable clinical targets in medicine.
BiotechDeep TechLongevityMedical DevicesHouston, US
Kevin Slawin(Founder and CEO)in
PartnerKevin M. Slawin· solo GP
Demeetra is a genome engineering company that develops precision gene-editing platforms — including Cas-CLOVER, Harbor-IN and Super piggyBac transposases and CleanCut CHO host cell lines — along with integrated cell line development and GMP manufacturing services.
BiotechDeep TechHealthtechLexington, US
Jack Crawford(CEO)in
PartnerKevin M. Slawin· solo GP
Eos SENOLYTIX develops senolytic peptides designed to restore cellular balance in aged or senescent cells across body organs, focusing on gerotherapeutics.
BiotechHealthtechLongevityHouston, US
Kevin Slawin, M.D.(Founder and CEO)inKevin Mark Slawin(Executive Officer, Director)in
BoardJerold Winograd(Director)Frank Bartlett McGuyer(Director)
PartnerKevin M. Slawin· solo GP
FIZE Medical develops an automated digital platform for fluid management in clinical settings, using real-time data to support clinical decision-making.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Noam Levine(Founder)in
PartnerKevin M. Slawin· solo GP
BiotechAuburndale, US
Jim Hutchens(Executive Officer, Director)inJohn Vacha(Executive Officer, Director)Ken Daignault(Director)Chris Bleck(Director)Robin Atlas(Director)
PartnerKevin M. Slawin· solo GP
K2bio operates a fully equipped, AAALAC-accredited contract vivarium facility in Houston supporting preclinical research for biotechnology and pharmaceutical companies.
BiotechDeep TechHealthtechHouston, US
Daniel Clark(Chief Financial Officer)inKieron Jones(Chief Executive Officer and Member of the Board of Directors)in
BoardKevin Slawin(Member of the Board of Directors)inAndrew DeSomma(Member of the Board of Directors)Gerard Fleury(Member of the Board of Directors)Clifford J. Stocks(Member of the Board of Directors)
PartnerKevin M. Slawin· solo GP
NexImmune is a biotechnology company developing antigen-directed immunotherapies based on its proprietary AIM nanoparticle platform, which mimics dendritic cell signaling to activate antigen-specific T cell responses.
BiotechMedical DevicesGaithersburg, US
Jonathan Schneck(Director)Alain Cappeluti(Executive Officer, Director)Kenneth Carter(Executive Officer, Director)
BoardJanis Naeve(Director)James Barrett(Director)
PartnerKevin M. Slawin· solo GP
Co-investorsPfizer Venture InvestmentsNew Enterprise Associates (NEA)
Numat develops metal-organic frameworks (MOFs) and manufactures them at industrial scale through an integrated campus with ISO 9001:2015 certified quality management.
Advanced ManufacturingCleantechDeep TechNew MaterialsIllinois, US
Ben Hernandez(Founder and Chief Executive Officer)inDr. Omar Farha(Founder and Chief Scientific Officer)
BoardT. Jay Collins(Director)Bill Kroll(Director)Luka Erceg(Director)Jeff Klunzinger(Director)
PartnerKevin M. Slawin· solo GP
Co-investorsGlobal BrainTEL Venture Capital, Inc.Universal Materials Incubator
Perseus SENOLYTIX is a gerotherapeutics company developing senolytic peptides to target senescent cells and restore cellular balance in aging organisms.
BiotechDeep TechLongevityMiami, US
Kevin Slawin, M.D.(Founder and CEO)inMichael A. Corsello, Ph.D.(Vice President of Operations)Daniel Jasinski, Ph.D.(Vice President of Research)
PartnerKevin M. Slawin· solo GP
Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions.
BiotechDeep TechHealthtechLongevityHouston, US
Kevin Slawin, M.D.(Founder and CEO)in
PartnerKevin M. Slawin· solo GP
Ponce Aurora develops mitochondrial-targeting longevity products including a full-body treatment and energy beverages powered by MitoXcel™ technology, which addresses age-related decline in mitochondrial function.
BiotechConsumerLongevityWellness & FitnessMiami, US
Kevin Slawin(Founder and CEO)inHélène Roth-Bergman(Chief Business and Commercial Officer)
PartnerKevin M. Slawin· solo GP
Ponce Aurora is a longevity company developing cosmetics, beverages, and supplements that target aging-related cellular issues using proprietary geropeptide technology.
ConsumerHealthtechLongevity
PartnerKevin M. Slawin· solo GP
Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications.
BiotechHealthtechSan Diego, US
Eric Ostertag(Executive Officer, Director)Mark Gergen(Executive Officer, Director)
BoardAdrian Howd(Director)David Hirsch(Director)
PartnerKevin M. Slawin· solo GP
Co-investorsAisling CapitalLongitude CapitalVivo Capital
PrintBio manufactures 3D-printed bioresorbable surgical meshes designed for hernia repair and soft tissue support.
BiotechHardwareHealthtechMedical DevicesNew MaterialsHouston, US
Kevin Slawin(Founder, Chairman and CEO)inFrank McGuyer(Founder, Chairman of the Board)
PartnerKevin M. Slawin· solo GP
Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan.
BiotechHealthtechLongevityHouston, US
Dr. Slawin(Founder & Leader)
PartnerKevin M. Slawin· solo GP
Sightly, based in Silicon Valley, makes software for planning and analyzing video advertising campaigns.
FintechMedia & EntertainmentSilicon Valley, US
Adam KatzinJeff TagliabueRalph MackinJohn Zdanowski(Executive Officer, Director)John McIntyre(Executive Officer, Director)
PartnerKevin M. Slawin· solo GP
Co-investors500 GlobalLaconiaPlug and Play Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bellicum Pharmaceutical, Inc.Bellicum Pharmaceuticals
Exits · 1
1 acquisitionsBellicum Pharmaceuticalsacq. by The University of Texas MD Anderson Cancer Center
Portfolio news
latest coverage across their companiesPoseida Therapeutics · ad-hoc-news.de · May 21, 2026
Eos SENOLYTIX · minichart.com.sg · May 15, 2026
PrintBio · the-daily-record.com · Feb 20, 2026
Numat Technologies · trysignalbase.com · May 27, 2025
Frequently asked questions
- How many investments has Rapha Capital Management, LLC made?
- Rapha Capital Management, LLC has 22 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Rapha Capital Management, LLC invest at?
- Rapha Capital Management, LLC invests at the Seed, Series A stages.
- What sectors does Rapha Capital Management, LLC focus on?
- Rapha Capital Management, LLC focuses on AgTech, Biotech, Healthtech, Medical Devices.
- Where is Rapha Capital Management, LLC located?
- Rapha Capital Management, LLC is headquartered in Surfside, US.
- Who does Rapha Capital Management, LLC co-invest with?
- Rapha Capital Management, LLC most often shares deals with Aisling Capital, Foresite Capital, Global Brain, among 14 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.